Systematic review of long-acting injectable antipsychotic medications approved from 2008 to october 2024 and agents in phase 3
{{output}}
Objective: The purpose of this systematic review is to provide a detailed summary of the long-acting injectable antipsychotic medications approved by the Food and Drug Administration (FDA) between 2008 to October 2024. We aim to ... ...
